December 14, 2022: We strongly support the inclusion of the VALID Act in the year-end omnibus spending package. This important bill will provide the FDA with the authority and resources necessary to ensure that the highest-risk diagnostic tests are valid and reliable.
Read More »Author: Caroline Bradford
NCHR encourages WSPI to do more to prevent long-term impact of diabetes in pregnancy
December 8, 2022: The National Center for Health Research (NCHR) agrees with the Women’s Preventive Services Initiative (WPSI) 2022 recommendations for diabetes screening after pregnancy. WPSI encourages continued diligence during the postpartum period in patients who were diagnosed with diabetes mellitus during pregnancy. That’s important because gestational diabetes increases a patient’s chances of developing type 2 diabetes.
Read More »Lasik Patients Should Be Warned of Complications, F.D.A. Draft Says
New York Times, December 7, 2022: FDA says many Lasik surgery patients develop double vision, dry eyes, difficulty driving at night and some have persistent eye pain. Diana Zuckerman says these FDA warnings should be required.
Read More »NCHR Comments on EPA Request for Information on Better Indoor Air Quality (IAQ) Management to Help Reduce COVID-19
December 5, 2022: Current IAQ standards are insufficient and poorly regulated at state and local levels to keep the public safe from increased COVID-19 transmission and other respiratory illnesses. Federal mandates would ensure that all indoor public spaces are properly assessed to improve ventilation rates. In the absence of greater regulation, the EPA must promote alternative methods of air filtration such as the Corsi-Rosenthal Box.
Read More »NCHR urges FDA to require more diversity in trials to improve accuracy of pulse ox devices
December 2, 2022: NCHR testified at an FDA meeting that there is strong evidence that commonly-used pulse oximeters are less reliable for patients with pigmented skin. The FDA’s current guidelines do not require product labeling to address the impact of skin pigmentation on pulse oximetry. While labeling is important to alert users to possible inaccuracies, it does not diminish the importance of developing devices that are effective for everyone.
Read More »